Reports
Global Genomics Market Share, Size, Outlook, Forecast: By Product: Consumables, Systems and Software, Services; By Technology: PCR, Sequencing, Microarray, Others; By Application; By End Use; Regional Analysis; Market Dynamics: SWOT Analysis; Value Chain Analysis; Competitive Landscape; Industry Events and Developments; 2024-2032
Global Genomics Market Outlook
The global genomics market was estimated at USD 21.46 billion in 2023 and is expected to grow at a CAGR of 9.5% over the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for genomics is driven by the genomic data pool, which has resulted in the development of the study operations, allowing physicians, biologists, and patients to further explore the genetic predisposition to certain illnesses. It is anticipated that the clinical implementation of this data pool will play a significant part in transforming the healthcare system with regard to providing more precise, efficient, and reliable alternatives for disease management.
Global Genomics Market: Properties and Applications
Genomics is referred to as the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The genomics market can be divided based on segments like product, technology, application, and end-use.
The genomics industry is broadly divided on the basis of product into:
- Consumables
- Systems and Software
- Services
Based on technology, the genomics market is divided into:
- PCR
- Sequencing
- Microarray
- Nucleic Acid Extraction and Purification
- Others
The genomics market is segmented on the basis of application into:
- Diagnostics
- Drug Discovery and Development
- Precision Medicine
- Agriculture and Animal Research
- Others
Based on end-uses, the genomics market is divided into:
- Research Centres and Academic and Government Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Others
The EMR report looks into the regional genomics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Global Genomics Market Analysis
The global genomics market is driven by the application of human genetic research in multiple government health programs such as consumer wellness programs, demographic screening, and others. The key objectives of the programs are to optimize preventive care for prevalent chronic diseases such as cancer and heart disease. The growing investment by government agencies, financing departments, and biotechnology firms to accelerate genomic research is expected to have significant implications for the genomics market reshaping. International financing agencies such as NIH and Welcome Trust are committed to offering to finance genetic research, which is supposed to boost genomic research in both advanced and emerging countries, further aiding the global genomics market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Genomics Market: Competitive Landscape
The report presents a detailed analysis of the following key players in the global genomics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Illumina, Inc. (NASDAQ: ILMN)
- Qiagen
- Eurofins Scientific
- Agilent Technologies, Inc.
- Oxford Nanopore Technologies
- F. Hoffmann-La Roche
- Bio-Rad Laboratories, Inc.
- BGI Group
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
Key Highlights of the Report:
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Technology, Application, End Use, Region |
| Breakup by Product | Consumables, Systems and Software, Services |
| Breakup by Technology | PCR, Sequencing, Microarray, Nucleic Acid Extraction and Purification, Others |
| Breakup by Application | Diagnostics, Drug Discovery and Development, Precision Medicine, Agriculture and Animal Research, Others |
| Breakup by End Use | Research Centres and Academic & Government Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Illumina, Inc. (NASDAQ: ILMN), Qiagen (NYSE: QGEN), Eurofins Scientific (EPA: ERF), Agilent Technologies, Inc. (NYSE: A), Oxford Nanopore Technologies, F. Hoffmann-La Roche (SWX: ROG), Bio-Rad Laboratories, Inc. (NYSE: BIO), BGI Group, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Genomics Market Analysis
8.1 Key Industry Highlights
8.2 Global Genomics Historical Market (2018-2023)
8.3 Global Genomics Market Forecast (2024-2032)
8.4 Global Genomics Market by Product
8.4.1 Consumables
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Systems and Software
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Services
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.5 Global Genomics Market by Technology
8.5.1 PCR
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Sequencing
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Microarray
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Nucleic Acid Extraction and Purification
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Others
8.6 Global Genomics Market by Application
8.6.1 Diagnostics
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Drug Discovery and Development
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Precision Medicine
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Agriculture and Animal Research
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Others
8.7 Global Genomics Market by End Use
8.7.1 Research Centres and Academic and Government Institutes
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Hospitals and Clinics
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Pharmaceutical and Biotechnology Companies
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Others
8.8 Global Genomics Market by Region
8.8.1 North America
8.8.1.1 Historical Trend (2018-2023)
8.8.1.2 Forecast Trend (2024-2032)
8.8.2 Europe
8.8.2.1 Historical Trend (2018-2023)
8.8.2.2 Forecast Trend (2024-2032)
8.8.3 Asia Pacific
8.8.3.1 Historical Trend (2018-2023)
8.8.3.2 Forecast Trend (2024-2032)
8.8.4 Latin America
8.8.4.1 Historical Trend (2018-2023)
8.8.4.2 Forecast Trend (2024-2032)
8.8.5 Middle East and Africa
8.8.5.1 Historical Trend (2018-2023)
8.8.5.2 Forecast Trend (2024-2032)
9 North America Genomics Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Genomics Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Genomics Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.2 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Genomics Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Genomics Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Illumina, Inc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 QIAGEN GmbH
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Eurofins GSC Lux SARL
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Agilent Technologies, Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Oxford Nanopore Technologies Limited
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 F. Hoffmann-La Roche
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Bio-Rad Laboratories, Inc.
16.2.7.1 Company Overview
16.2.7.2 Product Portfolio
16.2.7.3 Demographic Reach and Achievements
16.2.7.4 Certifications
16.2.8 BGI Group
16.2.8.1 Company Overview
16.2.8.2 Product Portfolio
16.2.8.3 Demographic Reach and Achievements
16.2.8.4 Certifications
16.2.9 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Genomics Market: Key Industry Highlights, 2018 and 2032
2. Global Genomics Historical Market: Breakup by Product (USD Billion), 2018-2023
3. Global Genomics Market Forecast: Breakup by Product (USD Billion), 2024-2032
4. Global Genomics Historical Market: Breakup by Technology (USD Billion), 2018-2023
5. Global Genomics Market Forecast: Breakup by Technology (USD Billion), 2024-2032
6. Global Genomics Historical Market: Breakup by Application (USD Billion), 2018-2023
7. Global Genomics Market Forecast: Breakup by Application (USD Billion), 2024-2032
8. Global Genomics Historical Market: Breakup by End Use (USD Billion), 2018-2023
9. Global Genomics Market Forecast: Breakup by End Use (USD Billion), 2024-2032
10. Global Genomics Historical Market: Breakup by Region (USD Billion), 2018-2023
11. Global Genomics Market Forecast: Breakup by Region (USD Billion), 2024-2032
12. North America Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
13. North America Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Europe Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Europe Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Asia Pacific Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Asia Pacific Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Latin America Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Latin America Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Middle East and Africa Genomics Historical Market: Breakup by Country (USD Billion), 2018-2023
21. Middle East and Africa Genomics Market Forecast: Breakup by Country (USD Billion), 2024-2032
22. Global Genomics Market Structure
Key Questions Answered in the Report
In 2023, the global genomics market attained a value of nearly USD 21.46 billion.
The market is projected to grow at a CAGR of 9.5% between 2024 and 2032.
The major market drivers include the growing scientific research and innovation focused on genomics, the growing prevalence of cancer, the introduction of government organised consumer wellness programmes, and growing technological advancements.
The key trends guiding the growth of the market include the development in non-invasive cancer screening-based research, growing clinical trials and increased funding for research, and the introduction of favourable government initiatives to advance genomics.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major genomics products in the market include consumables, systems and software, and services.
The significant technologies of genomics considered in the market report include PCR, sequencing, microarray, and nucleic acid extraction and purification, among others.
Diagnostics, drug discovery and development, precision medicine, and agriculture and animal research, among others, are the leading applications of genomics.
The various end uses of genomics include research centres and academic and government institutes, hospitals and clinics, and pharmaceutical and biotechnology companies, among others.
The major players in the market are Illumina, Inc., QIAGEN GmbH, Eurofins GSC Lux SARL, Agilent Technologies, Inc., Oxford Nanopore Technologies Limited, F. Hoffmann-La Roche, Bio-Rad Laboratories, Inc., and BGI Group, among others.
Analyst Review
The global genomics market attained a value of USD 21.46 billion in 2023, driven by the growing research and clinical trials in the field of genomes. Aided by the technological advancements and increased funding to accelerate genomic research, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 9.5%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on products, the genomics industry can be segmented into consumables, systems and software, and services. On the basis of technology, the genomics market is divided into PCR, sequencing, microarray, nucleic acid extraction and purification, and others. On the basis of applications, the industry is divided into diagnostics, drug discovery and development, precision medicine, and agriculture and animal research, among others. Based on end use, the industry is categorised into research centres and academic and government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others. The major regional markets for genomics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Illumina, Inc., Qiagen, Eurofins Scientific, Agilent Technologies, Inc., Oxford Nanopore Technologies, F. Hoffmann-La Roche, Bio-Rad Laboratories, Inc., and BGI Group, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER